Literature DB >> 30569110

DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.

Naoki Katase1, Shin-Ichiro Nishimatsu2, Akira Yamauchi3, Masahiro Yamamura4, Shuichi Fujita1.   

Abstract

Dickkopf‑related protein 3 (DKK3), which is a member of the Dickkopf WNT signaling pathway inhibitor family, is considered to be a tumor suppressor, due to its reduced expression in cancer cells and its ability to induce apoptosis when overexpressed by adenovirus. However, our previous study demonstrated alternative functions for DKK3 in head and neck squamous cell carcinoma (HNSCC). Our study reported that DKK3 expression was predominantly upregulated in HNSCC cell lines and tissue samples, and its expression was significantly correlated with poor prognosis. Furthermore, DKK3 overexpression in HNSCC cells significantly increased cancer cell proliferation, migration, invasion and in vivo tumor growth. These data have led to the hypothesis that DKK3 may exert oncogenic functions and may increase the malignant properties of HNSCC. The present study established a stable DKK3 knockdown cell line (HSC‑3 shDKK3) using lentivirus‑mediated short hairpin RNA, and assessed its effects on cancer cell behavior using MTT, migration and invasion assays. In addition, its effects on in vivo tumor growth were assessed using a xenograft model. Furthermore, the molecular mechanisms underlying the effects of DKK3 knockdown were investigated by microarray analysis, pathway analysis and western blotting. Compared with control cells, HSC‑3 shDKK3 cells exhibited significantly reduced proliferation, migration and invasion, and formed significantly smaller tumor masses when subcutaneously transplanted into nude mice. In addition, in HSC‑3 shDKK3 cells, the expression levels of phosphorylated (p)‑protein kinase B (Akt) (Ser473), p‑phosphoinositide 3‑kinase (PI3K) p85 (Tyr467), p‑PI3K p55 (Try199), p‑3‑phosphoinositide‑dependent protein kinase‑1 (PDK1) (Ser241) and total p38 mitogen‑activated protein kinase (MAPK) were reduced. Furthermore, phosphorylation of mechanistic target of rapamycin (mTOR) (Ser2448) was slightly decreased in HSC‑3 shDKK3 cells, which may be due to the increased expression of DEP domain‑containing mTOR‑interacting protein. Conversely, DKK3 overexpression in HSC‑3 shDKK3 cells rescued cellular proliferation, migration and invasion. With regards to expression levels, p‑PI3K and p‑PDK1 expression was not altered, whereas mTOR and p‑p38 MAPK expression was elevated. These data supported the hypothesis and indicated that DKK3 may contribute to the malignant phenotype of HNSCC cells via the PI3K/Akt/mTOR and MAPK signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30569110     DOI: 10.3892/ijo.2018.4667

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

Review 1.  The p38/MKP-1 signaling axis in oral cancer: Impact of tumor-associated macrophages.

Authors:  Zhenning Li; Fa-Yu Liu; Keith L Kirkwood
Journal:  Oral Oncol       Date:  2020-02-10       Impact factor: 5.337

2.  Chordin-Like 1 Regulates Epithelial-to-Mesenchymal Transition and Metastasis via the MAPK Signaling Pathway in Oral Squamous Cell Carcinoma.

Authors:  Qiuyu Wu; Zhichao Zheng; Junwei Zhang; Zhengguo Piao; Mengyu Xin; Xi Xiang; Antong Wu; Tianyu Zhao; Songkai Huang; Yu Qiao; Jiayu Zhou; Shaofen Xu; Haoyu Cheng; Lihong Wu; Kexiong Ouyang
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

Review 3.  Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials.

Authors:  Choudhary Harsha; Kishore Banik; Hui Li Ang; Sosmitha Girisa; Rajesh Vikkurthi; Dey Parama; Varsha Rana; Bano Shabnam; Elina Khatoon; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  Int J Mol Sci       Date:  2020-05-06       Impact factor: 5.923

4.  Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway.

Authors:  Jida Guo; Shengqiang Zhang; Jun Wang; Pengfei Zhang; Tong Lu; Linyou Zhang
Journal:  Front Oncol       Date:  2022-02-01       Impact factor: 5.738

Review 5.  Role of PI3K/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers.

Authors:  Soudeh Ghafouri-Fard; Ali Noie Alamdari; Yashar Noee Alamdari; Atefe Abak; Bashdar Mahmud Hussen; Mohammad Taheri; Elena Jamali
Journal:  Cancer Cell Int       Date:  2022-08-13       Impact factor: 6.429

Review 6.  MAPK Signaling Pathway in Oral Squamous Cell Carcinoma: Biological Function and Targeted Therapy.

Authors:  Yuxi Cheng; Juan Chen; Yuxin Shi; Xiaodan Fang; Zhangui Tang
Journal:  Cancers (Basel)       Date:  2022-09-23       Impact factor: 6.575

7.  Anethole induces anti-oral cancer activity by triggering apoptosis, autophagy and oxidative stress and by modulation of multiple signaling pathways.

Authors:  Camille Contant; Mahmoud Rouabhia; Lionel Loubaki; Fatiha Chandad; Abdelhabib Semlali
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.